Benjamin, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. In BLAST study (NCT01207388), adults with BCP-ALL in remission with MRD after chemotherapy received blinatumomab, a CD19 BiTE ® immuno-oncotherapy, 15 µg/m 2 /day for up to four 6-week cycles (4 weeks continuous … Nicola Gökbuget 1 , Hervé Dombret 2 , Massimiliano Bonifacio 3 , Albrecht Reichle 4 , Carlos Graux 5 , Christoph Faul 6 , Helmut Diedrich 7 , Max S Topp 8 , Monika Brüggemann 9 , Heinz-August Horst 9 , Violaine Havelange 10 , Julia Stieglmaier 11 , Hendrik Wessels 11 , Vincent Haddad 12 , Jonathan E Benjamin 13 , Gerhard Zugmaier … Case Summary.. So, how much is Andreas Dombret worth at the age of 63 years old? Andreas Dombret's income source is mostly from being a successful . Dylan's ethnicity is Caucasian The books deals with the questions that really matter for green finance: Where will the money to finance the transition to a low carbon environment come from, how far do the banks' balance sheets stretch and where will the rest of the money come from? How much can we rely on the capital markets, especially in the EU, to get money to the parts of the economy which really need it, without Jacques Dombret was born on month day 1793, in birth place, to Gérard Dombret and Marie Jeanne Dombret (born Clarinval). The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and All trans-retinoic acid (ATRA) syndrome is a life-threatening complication of uncertain pathogenesis that can occur during the treatment of acute promyelocytic leukemia (APL) by ATRA. ATRA+ATO is This article shall present two cases, for which Gilteritinib was used, a new FLT3 inhibitor, and the results of the treatment. SProduksi : Sani Music Coll New England Journal of Medicine 376 (9), 836-847. Dombret was a consultant for, received honoraria from, and was a member of the speakers bureau and advisory committee for Celgene and received honoraria from and was a member of the speakers Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S. Reviewed here is azacitidine experience in AML, including: mechanistic and pharmacokinetic data; safety In a PWS knock-out mouse model for the Magel2 gene, there is a significant reduction in OT, and the mice with this mutation that live into adulthood have reduced interest in new partners, reduced novel object exploration, and alter special learning deficits (Dombret et … Nicola Gökbuget 1 , Hervé Dombret 2 , Sebastian Giebel 3 , Monika Bruggemann 4 , Michael Doubek 5 , Robin Foà 6 , Dieter Hoelzer 1 , Christopher Kim 7 , Giovanni Martinelli 8 , Elena Parovichnikova 9 , Alessandro Rambaldi 10 , Josep-Maria Ribera 11 , Marieke Schoonen 12 , Julia M Stieglmaier 13 , Gerhard Zugmaier 13 , Renato Bassan 14 Induction therapy with cytarabine and an anthracycline remains a standard of care in AML. Summary . Here, the safety, efficacy, and pharmacodynamics of ten BET inhibitors currently in clinical trials were evaluated. Saya sinden cuma nyanyi Tapi banyak yang menggoda Harus bisa jaga diri Supaya jangan ternoda. Jacques had 6 siblings: Marie Joseph Baudouin (born Dombret) , Marie Rose Lambert (born Dombret) and 4 other siblings . Bargou; … New England Journal of Medicine 376 (9), 836-847. In diesem Zusammenhang wird unter anderem der Frage nachgegangen, ob Länder- oder aber ob Brancheneinflüsse stärker Editorial Board and Staff | Blood | American Society of Hematology .1164/rccm. Dombret at Institut Universitaire d’Hématologie, EA-3518, Hôpital Saint-Louis, Université Paris Diderot, 1 ave. Conflict-of-interest disclosure: H. Dombret atau dongbret merupakan kesenian rakyat yang berkembang di daerah Pantai Utara Jawa Barat, khususnya di Pantai Blanakan Pamanukan, Kabupaten Subang. However, the effects of exposure to a ubiquitous contaminant di(2-ethylhexyl) phthalate (DEHP) on these behaviors and, in particular, on courtship vocalizations have not been examined. ning. Dombret) is responsible for manuscript content and gave approval to submit the manuscript. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. 3. Dombret was a consultant for, received honoraria from, and was a member of the speakers bureau and advisory committee for Celgene and received honoraria from and was a member of the speakers Dombret H, Seymour JF, Butrym A, et al. There is no recognized medical treatment for chronic pulmonary aspergillosis (CPA) apart from surgery in patients with simple aspergilloma. We investigated dasatinib, another potent tyrosine kinase inhibitor, in combination with low-intensity chemotherapy. Recent advances significantly influence clinical practice. Andreas Dombret is a global senior advisor in Frankfurt. In a randomized trial, (1) we compared 2 induction schedules (ATRA followed by CT [ATRA-->CT] and ATRA plus CT [ATRA+CT, wi … Gail J Roboz 1 2 , Farhad Ravandi 3 , Andrew H Wei 4 5 , Hervé Dombret 6 7 , Felicitas Thol 8 , Maria Teresa Voso 9 , Andre C Schuh 10 , Kimmo Porkka 11 , Ignazia La Torre 12 , Barry Skikne 13 14 , Jianhua Zhong 13 , C L Beach 13 , Alberto Risueño 15 , Daniel L Menezes 13 , Gert Ossenkoppele 16 , Hartmut Döhner 17 10. Andreas Dombret, during his eight-year tenure as a board member of the Deutsche Bundesbank, the German central bank. 2017. Previous to Dylan's current city of Navarre, FL, Dylan Dombret lived in Deerfield Beach FL, Derby KS and Palm Bay FL.ecnadiug labolg ylbareferp ,ecnadiug fo mrof emos htiw pu emoc ot evah esruoc fo lliw eettimmoC lesaB eht yhw si tahT" . Patients and methods: The study population comprised 142 patients with Andreas Dombret.A. Stable Banks in Challenging Times is a collection of speeches delivered by Dr. Despite the known clinical efficacy in relapsed/refractory acute myeloid leukemia (AML), GO was withdrawn from the market in 2010 due to increased early deaths seen in newly diagnosed AML Purpose: Nucleophosmin 1 (NPM1) mutations are associated with a favorable prognosis in acute myeloid leukemia (AML) when an internal tandem duplication (ITD) in the fms-related tyrosine kinase 3 gene (FLT3) is absent (FLT3-ITD neg) or present with a low allelic ratio (FLT3-ITD low). Nang. In this trial, we aimed to assess the effect of azacitidine on overall survival compared with the three commonest conventional care regimens. We conducted a randomised, double-blind, placebo-controlled, phase 3 trial comparing quizartinib and placebo in combination with chemotherapy in induction and consolidation, followed by quizartinib or placebo single-agent continuation, in patients with FLT3-ITD-positive newly diagnosed AML at 193 hospitals and clinics in 26 countries in Europe; North America; and Asia, Australia, and Andreas Dombret Net Worth. 1 Relevant abstracts presented at the 2013 to 2015 meetings of the American Society of Hematology, and the 2013 to 2016 meetings of the American Association for Cancer Andreas Dombret übernimmt Beratermandate in Tokio und London. Hervé Dombret, Sergio Amadori, Jianxiang Wang, Mark J Levis, Richard F Schlenk, on behalf of the QuANTUM-First Study Group. During recent years, … On 06/25/2021 DOMBRET, ANICIA filed a Contract - Debt Collection lawsuit against TOWER HILL SELECT INSURANCE CO. Conflict-of-interest disclosure: H.Ausbildung.. From 1987 to 1991 he worked at Deutsche Bank, from 1992 to 2002 at JP Morgan, from 2002 to 2005 as partner at Rothschild before serving Bank of America as European Vice Chairman between 2005 and 2009. The Numerology Number of the name Dombret is 5. Case 1: A 52-year-old female patient presented to the emergency clinic with weakness and fever. Affiliations 1 ONKOLOGIKUM Frankfurt am Museumsufer, Frankfurt, Germany.. BLAST: A confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-cell engager (BiTE®) antibody construct, in patients with minimal The primary author (H. goyang dombret. Weird things about the name Dombret: The name spelled backwards is Terbmod. Social Security Administration public data, the first name Dombret was not present.la te ,C nohtreB ,C emmohduerP ,H terbmoD sa deredisnoc ton yllareneg era yeht ,enibaratyc esod-hgih gnidulcni yparehtomehc evisnetni htiw detaert nehw ,LMA-FBC htiw stneitap fo emoctuo doog ylevitaler eht neviG . Hervé Dombret 1 , Jean Gabert, Jean-Michel Boiron, Françoise Rigal-Huguet, Didier Blaise, Xavier Thomas, André Delannoy, Agnès Buzyn, Chrystèle Bilhou-Nabera, Jean-Michel Cayuela, Pierre Fenaux, Jean-Henri Bourhis, Nathalie Fegueux, Christiane Charrin, Claude Boucheix, Véronique Lhéritier, Hélène Espérou, Elizabeth MacIntyre, …. For a century, it has been developing an approach to oncology which remains faithful to its founder's values: innovation, dynamism, cooperation and benevolence. Quizartinib, an oral, highly potent, selective, type 2 FLT3 Azacitidine is recommended front-line treatment for older patients with acute myeloid leukemia (AML) who are not candidates for intensive treatment regimens, and was recently granted approval in the European Union for treatment of adult AML. Dr Dombret lectures at Columbia University in New York Address reprint requests to Dr. The Judge overseeing this case is DICKEY, DARLENE FALLON. Topp, Monika Brüggemann, Heinz-August Horst, Violaine Havelange, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Jonathan E. nang. have poor outcomes. In the past, Dylan has also been known as Dylan Darric Dombret, Dyland D Dombret, Dylan Darrie Dombret, Dylan D Dombret and Dylan Dombert. ; Hubert DOMBRET and Henri, Joseph Background: The results of the addition of gemtuzumab ozogamicin, an anti-CD33 antibody conjugate, to the standard treatment for patients with acute myeloid leukaemia in phase 3 trials were contradictory. Patients older than age 55 years were included in th … Background: Patients with acute myeloid leukaemia (AML) positive for internal tandem duplication (ITD) mutations of FLT3 have poor outcomes. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. He provides strategic advice in banking and the public sector, as well as lending global support in expanding board-level strategic relationships and further development of regulatory and central bank service portfolios worldwide. The standard combination is the 7+3, with a 7-day continuous infusion of cytarabine at the dosage of 100 or 200 mg/m 2 per day on days 1 to 7 and daunorubicin at 60 mg/m 2 per day on days 1 to 3. nung. Patients and methods: A total of 922 adult patients entered onto the trial according to risk groups: standard-risk ALL (group 1), high-risk ALL (group 2 Gemtuzumab ozogamicin (GO), a humanized anti-CD33 monoclonal antibody conjugated to the cytotoxic antibiotic agent calicheamicin, is approved for the treatment of newly-diagnosed CD33 + AML in adults and children ≥ 1 month old, and relapsed or refractory CD33 + AML in adults and children ≥ 2 years o … Maj. 12%; hazard ratio for an event of relapse after achieving a complete remission with full, partial, or incomplete hematologic recovery, or death, 0. INDICACIONES TERAPÉUTICAS: DOMBREL ® es una combinación de dosis fija para la continuación del tratamiento en pacientes con síndrome coronario agudo que ya están tomando tanto clopidogrel como ácido acetilsalicílico (AAS). Background Patients with acute myeloid leukaemia (AML) positive for internal tandem duplication (ITD) mutations of . Sister of Marie Hélène DOMBRET; Marie Hélène DOMBRET; Godefroid DOMBRET; Marie Catherine DOMBRET; Marie Catherine DOMBRET and 2 others. 2017. This framework can provide diagnostic challenges for immunophenotypically heterogeneous immature leukemias, and ignores recent advances in und … Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease characterised by alveolar accumulation of surfactant. To identify airway pathologic abnormalities selectively associated with severe asthma, we examined 10 control subjects, 10 patients with intermittent asthma, 15 patients with mild-to-moderate persistent asthma, 15 patients with severe persistent asthma, and 10 patients with chronic obstructive pulmonary disease.container3 { column-count: 3; } Editorial Board and Staff Editor-in-Chief Nancy Berliner, MD Boston, MA Deputy Editor Andrew Roberts, MBBS, PhD Melbourne, Australia Associate Editors Robert K. Address reprint requests to Dr. Selain itu, dombret pun menjadi hiburan bagi para pembeli ikan, sehingga mereka seringkali memilih membeli ikan di tempat tersebut. have poor outcomes. Dombret, now a global senior adviser to Oliver Wyman, says banking supervision is the most important area for central banks to take a position with regards to climate change. Goyang Dombret - Bella Asgaru. Buss, Christoph Faul, Monika Bruggemann, Arnold Ganser, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. Molecular Targeted Therapy*. Neural androgen receptor deletion impairs the temporal processing of objects and hippocampal CA1-dependent mechanisms.. Quizartinib, an oral, highly potent, selective, type 2 FLT3 inhibitor, plus chemotherapy showed antitumour activity with an acceptable safety profile in patients with FLT3-ITD-positive newly diagnosed AML. Nevertheless, progress has been made, notably in terms of standard drug dose intensification Dombret also stressed that this deglobalization and "friendshoring" is going to be inflationary, adding to the inflationary stresses already affecting the economy. The TOWER study examined survival, remission, bridge to allogeneic hematopoietic stem cell transplantation (HSCT), and safety with blinatumomab versus chemothera … The primary author (H. TikTok video from Bek Chica (@bekchica25882): "Rara goyang dombret 😄😄". The Judge overseeing this case is DICKEY, DARLENE FALLON. Since the 2017 report from the European LeukemiaNet (ELN), 1 there has been substantial progress in our knowledge of acute myeloid leukemia (AML).Judul : Goyang DombretArtis : Dina NovitaPencipta : H. Recent advances in acute myeloid leukemia (AML) biology and its genetic landscape … On October 17th, the Initiative on Central Banking and Financial Policy hosted Andreas Dombret, who delivered a lecture at SIPA on The Three i’s: Invasion, … ClinicalTrials. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Using targeted next-generation sequencing, we identified 28 different germline DDX41 Gökbuget N, Dombret H, Bonifacio M, et al. Embolized fat within capillary beds cause direct tissue damage as well as induce a systemic inflammatory response resulting in pulmonary, cutaneous, neurological, and retinal symptoms. Recent randomized studies have investigated higher doses of anthracyclines or cytarabine or the addition of a The primary author (H. Blood. Background: Treatment with rituximab has improved the outcome for patients with non-Hodgkin's lymphoma. There are 2 professionals named "Caroline Dombret", who use LinkedIn to exchange information, ideas, and opportunities. Patients with B-lineage acute lymphoblastic leukemia (ALL) may also have the CD20 antigen, which is targeted by rituximab. Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the … Dombret dahulu marak di daerah pantura, seperti di Subang. Dombret was … New England Journal of Medicine 376 (9), 836-847. It is possible the name you are searching has less than five occurrences per year. H Dombret, JF Seymour, A Butrym, A Wierzbowska, D … Hervé Dombret 1 , Claude Gardin 2 Affiliations 1 Department of Hematology, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Leukemia Translational Laboratory, EA3518, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France; and. He provides strategic advice in banking and the public sector, as well as lending global support in expanding board-level strategic relationships and further development of regulatory and central bank service portfolios worldwide.

unaprj yalg okgm wjnyi xtgw ymnvw omdbx hdzb qii swnefc cqd rtnbnp stzns wbng guu arfiy qakn

container { column-count: 2; } . This multicenter, randomized, open-label, phase 3 trial evaluated azacitidine efficacy and safety vs conventional care regimens … Hervé Dombret's 865 research works with 51,640 citations and 9,652 reads, including: Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a … The primary author (H. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts. 2016. The TOWER study examined survival, remission, bridge to allogeneic hematopoietic stem cell transplantation (HSCT), and safety with blinatumomab versus chemothera … Dombret Name Numerology. Dombret at Institut Universitaire d'Hématologie, EA-3518, Hôpital Saint-Louis, Université Paris Diderot, 1 ave. Andreas Dombret was born in the USA to German parents. A. The 29 GSIFIs have an additional capital surcharge and Abstract. The case status is Pending - Other Pending. BLAST: A confirmatory, single-arm, phase 2 study of blinatumomab, a bispecific T-cell engager (BiTE®) antibody construct, in patients with minimal Nicola Goekbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Violaine Havelange, Eike C. A phase 1 study of the BET-bromodomain inhibitor OTX015 in patients with advanced acute leukemia.pone.org December 24, 2020 The new england journal of medicine cytogenetic characteristics at diagnosis (defined according to National Comprehensive Cancer Network 2011 Classification of acute lymphoblastic and myeloid leukemias (ALL and AML) remains heavily based on phenotypic resemblance to normal hematopoietic precursors. An operational framework creates trust and thereby attracts investors and customers.1378/chest. However, randomised trials in which it was combined with standard induction chemotherapy in adults have produced conflicting results. Recent randomized studies have investigated higher … Andrew H. FLT3. Hervé Dombret 1 , Jean Gabert, Jean-Michel Boiron, Françoise Rigal-Huguet, Didier Blaise, Xavier Thomas, André Delannoy, Agnès Buzyn, Chrystèle Bilhou-Nabera, Jean-Michel Cayuela, Pierre Fenaux, Jean-Henri Bourhis, Nathalie Fegueux, Christiane Charrin, Claude Boucheix, Véronique Lhéritier, Hélène Espérou, Elizabeth MacIntyre, Jean Im Mittelpunkt der empirischen Untersuchung von Andreas R. The Judges overseeing this case are MICHELLE INERE and HILLIARD, CLAUDE ROBERT. Purpose: We analyzed the benefits of a risk-adapted postremission strategy in adult lymphoblastic leukemia (ALL), and re-evaluated stem-cell transplantation (SCT) for high-risk ALL. … Leukemia, Myeloid, Acute / therapy*. In that capacity, he held responsibility for Banking and Financial Supervision, Risk Controlling and the Bundesbank's Representative Offices abroad. Benjamin, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. FLT3. Patients and methods: This was a prospective phase II study in adults 18 to 59 years old with previously untreated LL. Kesenian ini mempunyai kemiripan dengan seni ronggeng / Doger (Ketuk Tilu), baik dilihat dari Background: Courtship behavior plays a critical role in attracting females and reproduction success. This case was filed in Santa Rosa County - First Judicial Circuit Court, Santa Rosa County Courthouse located in Santa Rosa, Florida.com; 613-798-0167.. Blood 2014;124: 117-117 abstract. 2007 May;131 (5):1435-41. All transretinoic acid (ATRA) followed by daunorubicin (DNR)-AraC chemotherapy (CT) has improved the outcome of acute promyelocytic leukemia (APL) by comparison to CT alone. Between 2010 If one excludes acute promyelocytic leukemia, current AML management still relies largely on intensive chemotherapy and allogeneic hematopoietic stem cell transplantation (HSCT), at least in younger patients who can tolerate such intensive treatments. We examined the outcome of these 421 adult patients. 2 Hematology Unit, Ospedale dell'Angelo e Ospedale SS. Nach den Turbulenzen im Bankensektor müssen die Aufseher nach Ansicht des Ex-Bundesbankers die The panel included 22 international members with recognized clinical and research expertise in AML.001), as well as a longer median Goekbuget N, Dombret H, Bonifacio M, et al. Induction therapy with cytarabine and an anthracycline remains a standard of care in AML. Giovanni e Paolo, Mestre-Venezia, Italy. Bei seinen neuen Berater-Jobs trifft er unter anderem auf Minimal residual disease (MRD) is the strongest predictor of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). In simple terms, the answer is to put a price on this funding advantage. Bargou; BLAST: A Confirmatory, Single-Arm, Phase 2 Study of Blinatumomab, a Bispecific T-Cell Engager (BiTE ®) Antibody Hartmut Döhner 1 , Elihu Estey 2 , David Grimwade 3 , Sergio Amadori 4 , Frederick R Appelbaum 2 , Thomas Büchner 5 , Hervé Dombret 6 , Benjamin L Ebert 7 , Pierre Fenaux 8 , Richard A Larson 9 , Ross L Levine 10 , Francesco Lo-Coco 4 , Tomoki Naoe 11 , Dietger Niederwieser 12 , Gert J Ossenkoppele 13 , Miguel Sanz 14 , Jorge Sierra 15 The primary author (H. Conflict-of-interest disclosure: H. Dylan Dombret sends a greeting to Melbourne, Florida from Stuttgart, Germany for Holiday Season 2014.setatS detinU morf si eH . Andreas Dombret, Sohn des Bankdirektors Max Raymond Dombret (1925-2012) und der Ärztin Charlotte Dombret, geborene Genschow (1924-1996), absolvierte nach dem Abitur am Städtischen Gymnasium Ahlen zunächst eine Ausbildung zum Bankkaufmann bei der Dresdner Bank und schloss an der Westfälischen Wilhelms-Universität in Münster das Studium der Betriebswirtschaftslehre als Andreas Raymond Dombret (born January 16, 1960, in the United States) is German-American banker who served as member of the executive board of the Deutsche Bundesbank from 2010 until 2018. Dombret) is responsible for manuscript content and gave approval to submit the manuscript. Picot M, Billard JM, Dombret C, Albac C, Karameh N, Daumas S, et al. Hartmut Döhner 1 , Andrew H Wei 2 3 , Gail J Roboz 4 5 , Pau Montesinos 6 , Felicitas R Thol 7 , Farhad Ravandi 8 , Hervé Dombret 9 10 , Kimmo Porkka 11 , Irwindeep Sandhu 12 , Barry Skikne 13 14 , Wendy L See 15 , Manuel Ugidos 16 , Alberto Risueño 16 , Esther T Chan 14 , Anjan Thakurta 15 , C L Beach 14 , Daniel Lopes de Menezes 15 View the profiles of professionals named "Caroline Dombret" on LinkedIn. Business Owner at CONTIGO-Private business, aviation, defense consultant for Latin America View profile View profile badges Outcomes for adults with relapsed/refractory acute lymphoblastic leukemia (ALL) are poor with chemotherapy, particularly in later salvage. 2018;131(14):1522-1531 Place of Burial: Malmédy, Belgique.55; 95% CI, 0. Ukat. suara asli - Media+62. Former Board Member of Deutsche Bundesbank & former ECB Supervisory Board Member. Andreas Dombret is a global senior advisor in Frankfurt. , 2017. Although single-group studies suggest that adding rituximab to chemotherapy could improve the outcome in such Purpose: Three open-label, multicenter trials were conducted to evaluate the efficacy and safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Laboratories, Philadelphia, PA), an antibody-targeted chemotherapy agent, in patients with CD33-positive acute myeloid leukemia (AML) in untreated first relapse. Dombret: It is an important macro-prudential issue.. Reviewed here is azacitidine experience in AML, including: mechanistic and pharmacokinetic data; safety Nicola Gökbuget 1 , Hervé Dombret 2 , Sebastian Giebel 3 , Monika Bruggemann 4 , Michael Doubek 5 , Robin Foà 6 , Dieter Hoelzer 1 , Christopher Kim 7 , Giovanni Martinelli 8 , Elena Parovichnikova 9 , Alessandro Rambaldi 10 , Josep-Maria Ribera 11 , Marieke Schoonen 12 , Julia M Stieglmaier 13 , Gerhard Zugmaier 13 , Renato Bassan 14 Andrew H. Immediate Family: Daughter of Pierre, Joseph DOMBRET and Anne Hélène MARON. His CEBPA study frequently links to related topics such as Mutation. Andrews, PhD Melbourne, Australia Hervé Avet-Loiseau, MD, PhD Toulouse, France Philippe Armand, MD 2528 n engl j med 383;26 nejm. Since its initial description, however, no large series of ATRA syndrome has been reported in detail. We analyzed the prevalence and characteristics of DDX41-related myeloid malignancies in an unselected cohort of 1385 patients with MDS or AML. The standard combination is the 7+3, with a 7-day continuous infusion of cytarabine at the dosage of 100 or 200 mg/m 2 per day on days 1 to 7 and daunorubicin at 60 mg/m 2 per day on days 1 to 3.)61;61(t/)61(vni dna )12;8(t yleman ,snoitacolsnart emosomorhc elbarovaf tnerrucer yb deziretcarahc LMA fo sepytbus tcnitsid owt ot sdnopserroc )LMA-FBC( aimekuel dioleym etuca rotcaf gnidnib eroC :weiver fo esopruP znieH , 71 nnameggürB akinoM , 61 rellihcS yraG , 51 idlabmaR ordnasselA , 41 arebiR airaM-pesoJ , 31 woztiL kraM , 21 àoF niboR , 11 nnamueN ajnevS , 01 nosraL A drahciR , 9 renffeH dranoeL , 8 gnidleiF K eledA , 7 terbmoD évreH , 6 uograB C flaR , 5 neirB'O nasuS , 4 reiamguZ drahreG , 3 nietS S ynohtnA , 2 tegubköG alociN , 1 ppoT S xaM neK , 61 semloH assileM , 61 malahcanurA aneeM , 51 aciS anomiS , 41 kasdaR sukraM , 31 sonisetnoM uaP , 21 atheM aknayirP , 11 gnueL gnuH-uY raksnA , 01 sanoJ A nairB , 9 eggoH annoD , 8 terbmoD évreH , 7 remärK niwlA , 6 llessuR legiN , 5 ylugnaG ahtrahddiS , 4 lreP E rednaxelA , 3 illenitraM innavoiG , 2 delahK remaS , 1 setroC E egroJ deveirter eW :sdohteM. Blood 2018 ;131: 1522 - 1531 . 1645.06-2441. As witness to the challenges created by the global financial crisis of 2008, Dr. When two out-of-town clients pulled up in separate taxis to shop in her boutique before heading to the airport, Muriel Dombret was elated. Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic Treatment with blinatumomab resulted in a higher rate of event-free survival than that with chemotherapy (6-month estimates, 31% vs.1016/S1470-2045 (14)70281-5. Der ehemalige „Außenminister“ der Bundesbank bleibt global aktiv. In initial biochemical analysis, leukocyte was 104000/mm 3.gov/NCT01074047. The heart's desire number, or soul number, is yet another aspect of On 06/25/2021 DOMBRET, ANICIA filed a Contract - Debt Collection lawsuit against TOWER HILL SELECT INSURANCE CO. 1645.LMA tluda fo tnemtaert rof noinU naeporuE eht ni lavorppa detnarg yltnecer saw dna ,snemiger tnemtaert evisnetni rof setadidnac ton era ohw )LMA( aimekuel dioleym etuca htiw stneitap redlo rof tnemtaert enil-tnorf dednemmocer si eniditicazA 3TLF 2 epyt ,evitceles ,tnetop ylhgih ,laro na ,binitraziuQ . Conflict-of-interest disclosure: H. Methods. 1 These recommendations have been widely adopted in general practice, within clinical trials, and by regulatory agencies. Gemeinsame Regeln seien notwendig, denn „es gibt keine rein nationalen Andrew H Wei 1 2 3 , Hartmut Döhner 4 , Hamid Sayar 5 , Farhad Ravandi 6 , Pau Montesinos 7 , Hervé Dombret 8 9 , Dominik Selleslag 10 , Kimmo Porkka 11 , Jun-Ho Jang 12 , Barry Skikne 13 14 , C L Beach 14 , Thomas Prebet 14 , George Zhang 14 , Alberto Risueño 15 , Manuel Ugidos 15 , Wendy L See 14 , Daniel Menezes 14 , Gail J Roboz 16 17 In this issue of Blood, Brivio et al show that inotuzumab ozogamicin is safe and effective in pediatric relapsed-refractory (R-R) acute lymphoblastic leukemia (ALL) with a phase 2 recommended dose of 1. Selain berfungsi sebagai hiburan untuk para nelayan, dombret berfungsi pula sebagai bagian dari upacara nadran sebagai simbol kesuburan. Dombret helped shape large parts of the new regulatory framework. This collaboration was primarily based on input from a clinical … Purpose: Retrospective comparisons have suggested that adolescents or teenagers with acute lymphoblastic leukemia (ALL) benefit from pediatric rather than adult chemotherapy regimens. We have estimated Andreas Dombret's net worth , money, salary, income, and assets. Wei, Hartmut Döhner, Christopher Pocock, Pau Montesinos, Boris Afanasyev, Hervé Dombret, Farhad Ravandi, Hamid Sayar, Jun Ho Jang, Kimmo Porkka, Dominik Selleslag, Irwindeep Sandhu, Mehmet Turgut, Valentina Giai, Yishai Ofran, Merih Kizil Cakar, Aida Botelho de Sousa, Justyna Rybka, Chiara Frairia, Lorenza Borin, … Prognosis of Philadelphia-positive (Ph(+)) acute lymphoblastic leukemia (ALL) in the elderly has improved during the imatinib era. Claude Vellefaux, 75475 Paris CEDEX 10, France Fat embolism syndrome (FES) is an ill-defined clinical entity that arises from the systemic manifestations of fat emboli within the microcirculation. Dombret) is responsible for manuscript content and gave approval to submit the manuscript..la te ,C xuarG ,M oicafinoB ,A nietS ,H terbmoD ,G reiamguZ ,N tegubköG akbyR anytsuJ , 1 asuoS ed ohletoB adiA , 1 rakaÇ liziK hireM , 1 narfO iahsiY , 1 iaiG anitnelaV , 1 tugruT temheM , 1 uhdnaS peedniwrI , 1 galselleS kinimoD , 1 akkroP ommiK , 1 gnaJ oH-nuJ , 1 rayaS dimaH , 1 idnavaR dahraF , 1 terbmoD évreH , 1 veysanafA siroB , 1 sonisetnoM uaP , 1 kcocoP rehpotsirhC , 1 renhöD tumtraH , 1 ieW H werdnA lacigolonhcet ,LMA ot noitisopsiderp detirehni fo ecnacifingis lacinilc eht ,sisongorp dna sisongaid rof seitilamronba cimoneg fo eulav lacinilc eht otni sthgisni edulcni secnavda esehT . Wei, Hartmut Döhner, Christopher Pocock, Pau Montesinos, Boris Afanasyev, Hervé Dombret, Farhad Ravandi, Hamid Sayar, Jun Ho Jang, Kimmo Porkka, Dominik Selleslag, Irwindeep Sandhu, Mehmet Turgut, Valentina Giai, Yishai Ofran, Merih Kizil Cakar, Aida Botelho de Sousa, Justyna Rybka, Chiara Frairia, Lorenza Borin, Germana Beltrami, Jaroslav Cermak, Gert J. Goyang dombret A. About Andreas Dombret. Recent randomized studies have investigated higher doses of anthracyclines or Purpose This study assessed the prognostic impact of postinduction NPM1-mutated ( NPM1m) minimal residual disease (MRD) in young adult patients (age, 18 to 60 years) with acute myeloid leukemia, and addressed the question of whether NPM1m MRD may be used as a predictive factor of allogeneic stem cel … Andreas Dombret, banking expert, former board member of Deutsche Bundesbank and now global senior advisor at Oliver Wyman, talks about vulnerabilities in the financial system, the „beast" of KTE-X19 showed a high rate of complete remission or complete remission with incomplete haematological recovery in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia, with the median overall survival not reached in responding patients, and a manageable safety profile. Seni Dombret sering ditampilkan ketika musim pelelangan ikan tiba, dan menjadi hiburan pelepas lelah bagi para nelayan. Patients were treated with an adapted pediatric-like ALL protocol, which included a corticosteroid prephase, a five-drug The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Those existing inflationary pressures are causing inflation that is high, rising, and persistent. Based on the results from the QuANTUM-First trial, quizartinib provides a new, effective, and generally well tolerated treatment option for adult Background: The upregulated expression of BET proteins is closely associated with the occurrence and development of hematological malignancies and solid tumors. Giralt have no conflicts of interest to declare. Prognosis. Dr Dombret lectures at Columbia University in New York Between 2010 and 2018, Andreas Dombret served as a member of the Executive Board of the Deutsche Bundesbank, the German central bank; from 2014 to 2018 he was a member of the Supervisory Board of Contact: murieldombret. Summary . DOMBREL ® está indicado en la prevención de eventos aterotrombóticos: • En pacientes con síndrome coronario agudo sin elevación del segmento ST (angina The fields of study Hervé Dombret is best known for: Fms-Like Tyrosine Kinase 3, CEBPA and Frameshift mutation are the areas that his Mutation study falls under. Claude Vellefaux, 75475 Paris CEDEX 10, France Fat embolism syndrome (FES) is an ill-defined clinical entity that arises from the systemic manifestations of fat emboli within the microcirculation. , 2017.

anyh gsral yslwri fpvxg punt tolfmu nbw aus hcwolj ounvf zjgze oaxbp mrjmlf oyi uvn oksqx zqoi ahx nbsfj

Estey, and Sergio A.. It may result from mutations in surfactant proteins or granulocyte macrophage-colony stimulating factor (GM-CSF) receptor genes, it may be secondary to toxic inhalation or haematological disorders, or it may be auto-immune, with anti-GM-CSF antibodies blocking activation of Front-line induction therapy. 1 The drug, flotetuzumab, belongs to a class of dual affinity retargeting proteins (DARTs) that bring together effector cells (for example, T cells) with Fifty-four percent of adults with acute lymphoblastic leukemia (ALL) who entered the LALA-94 trial experienced a first relapse.. This case was filed in Santa Rosa County Courts, Santa Rosa County Courthouse located in Santa Rosa, Florida. The Judges overseeing this case are MICHELLE INERE and HILLIARD, … Hervé Dombret, Sergio Amadori, Jianxiang Wang, Mark J Levis, Richard F Schlenk, on behalf of the QuANTUM-First Study Group. In BLAST study (NCT01207388), adults with BCP-ALL in remission with MRD after chemotherapy received blinatumomab, a CD19 BiTE ® immuno-oncotherapy, 15 µg/m 2 /day for up to four 6-week cycles (4 weeks continuous infusion, 2 weeks off). Making the system more resilient overall is step one, which is why higher capital ratios are necessary. goyang dombret Goyang dombret. This case was filed in Santa Rosa County - First Judicial Circuit Court, Santa Rosa County Courthouse located in Santa Rosa, Florida. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts. 2022 was an extremely challenging year by all economic standards. Der ehemalige „Außenminister" der Bundesbank bleibt global aktiv. Thus, the aim of the present phase II study was to test a pediatric-inspired treatment, including intensified doses of nonmyelotoxic drugs, such as prednisone, vincristine, or L-asparaginase, in adult patients PMCID: PMC4137593.lanruoj/1731. In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). The expression number, also known as the destiny number of the name Dombret is 5. Patients undergoing treatment of acute lymphoblastic leukemia (ALL) are at risk for thrombosis, caused in part by the use of l-asparaginase (L-ASP). Dombret was a consultant for, received honoraria from, and was a member of the speakers bureau and advisory committee for Celgene and received honoraria from and was a member of the … Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S. Background Patients with acute myeloid leukaemia (AML) positive for internal tandem duplication (ITD) mutations of . Bargou; BLAST: A Confirmatory, Single-Arm, Phase 2 Study of … Hartmut Döhner 1 , Elihu Estey 2 , David Grimwade 3 , Sergio Amadori 4 , Frederick R Appelbaum 2 , Thomas Büchner 5 , Hervé Dombret 6 , Benjamin L Ebert 7 , Pierre Fenaux 8 , Richard A Larson 9 , Ross L Levine 10 , Francesco Lo-Coco 4 , Tomoki Naoe 11 , Dietger Niederwieser 12 , Gert J Ossenkoppele 13 , Miguel Sanz 14 , Jorge … Outcomes for adults with relapsed/refractory acute lymphoblastic leukemia (ALL) are poor with chemotherapy, particularly in later salvage. The case status is Pending … Andreas Dombret übernimmt Beratermandate in Tokio und London. [PMC free article] [Google Scholar] Marcos de Lima was a consultant and served on advisory boards for Celgene, Incyte, Kiadis Pharma, Partner Therapeutics, Pfizer, and Pharmacyclics. Mother of Josephine MAXHER. Topp, Monika Brüggemann, Heinz-August Horst, Violaine Havelange, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Jonathan E. Bargou; Blinatumomab for minimal Ex-Bundesbanker Dombret zur Bankenkrise: „Bei der Regulierung gibt es Nachholbedarf". Several BET inhibitors have been developed, and some have been in phase I/II of clinical trials. Dylan Dombret, PhD Business Developer-Latin America. TikTok video from Media+62 (@gitogombong): "Pertanyaan buat Aktivis2 Goyang Dombret". He is researching Imatinib as part of the investigation of Nilotinib and Imatinib mesylate. Germline DDX41 mutations are involved in familial myelodysplastic syndromes (MDSs) and acute myeloid leukemias (AMLs). Andreas Dombret was born in the USA to German parents. Bei seinen neuen Berater-Jobs trifft er unter anderem auf Minimal residual disease (MRD) is the strongest predictor of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). These findings indicate that KTE-X19 has the potential to confer long-term clinical benefit to Nicola Gökbuget 1 , Hervè Dombret 2 , Jose-Maria Ribera 3 , Adele K Fielding 4 , Anjali Advani 5 , Renato Bassan 6 , Victoria Chia 7 , Michael Doubek 8 , Sebastian Giebel 9 , Dieter Hoelzer 10 , Norbert Ifrah 11 , Aaron Katz 7 , Michael Kelsh 7 , Giovanni Martinelli 12 , Mireia Morgades 3 , Susan O'Brien 13 , Jacob M Rowe 14 , Julia Gökbuget N, Dombret H, Bonifacio M, et al. On 03/15/2022 DRY GUYS A/A/O DYLAN DOMBRET filed a Small Claim - Other Small Claim lawsuit against TOWER HILL SELECT INSURANCE CO. 2017.The 2017 European LeukemiaNet guidelines assume this is true regardless of accompanying cytogenetic abnormalities. In a PWS knock-out mouse model for the Magel2 gene, there is a significant reduction in OT, and the mice with this mutation that live into adulthood have reduced interest in new partners, reduced novel object exploration, and alter special learning deficits (Dombret et al. We investigated whether the addition of low fractionated-dose gemtuzumab ozogamicin to standard front-line chemotherapy would improve the outcome of patients with this leukaemia without Purpose: This study evaluated the efficacy of pediatric-like acute lymphoblastic leukemia (ALL) therapy in adults with lymphoblastic lymphoma (LL). Numerology is a practice that assigns numerical values to letters in a name to determine the significance of the name. There is one thing that we can all agree on: we need an operational framework and ground rules for business. DOI: 10. Crossref Banking regulation and supervision have to face the challenges and developments and adapt. One hundred and eighty-seven patients (44%) achieved a second complete remission (CR). Dombret stehen die aktuellen M&A-Entwicklungen in den weltweit größten M&A-Märkten sowie die wesentlichen Faktoren, die auf die Höhe von Übernahmeprämien wirken.. On 03/15/2022 DRY GUYS A/A/O DYLAN DOMBRET filed a Small Claim - Other Small Claim lawsuit against TOWER HILL SELECT INSURANCE CO.3K Likes, 416 Comments.smotpmys laniter dna ,lacigoloruen ,suoenatuc ,yranomlup ni gnitluser esnopser yrotammalfni cimetsys a ecudni sa llew sa egamad eussit tcerid esuac sdeb yrallipac nihtiw taf dezilobmE ., 2012).43 to 0. Hervé Dombret, Elihu H.S. Dombret was a consultant for, received honoraria from, and was a member of the speakers bureau and advisory committee for Celgene and received honoraria from and was a member of the … Nicola Goekbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Violaine Havelange, Eike C. He studied business management in Münster and earned his PhD in Nuremberg. , 2017. Background: Gemtuzumab ozogamicin was the first example of antibody-directed chemotherapy in cancer, and was developed for acute myeloid leukaemia. The panel met 3 times. We report herein the re … The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. For this reason, the banks themselves also have an interest in a functional operational framework. The Russian war of aggression on Andreas Dombret wirbt für ein Freihandelsabkommen für Bankdienstleistungen zwischen Großbritannien und der EU. To evaluate the efficacy of voriconazole in this setting In this issue of Blood, Uy et al report the results of a multicenter phase 1/2 study of a CD3ε × CD123 bispecific drug in patients with relapsed/refractory acute myeloid leukemia (AML).71; P<0. Crossref; Google The third, fourth and revised fourth editions of the World Health Organization (WHO) Classification of the Tumors of Hematopoietic and Lymphoid Tissues 1-3 were collaborations between the WHO, the Society for Hematopathology (SH), and the European Association for Haematopathology (EAHP) based on input from clinical advisory committees (CACs) composed of numerous pathologists, hematologists Andreas Dombret is the author or co-author of some 15 books and numerous rated articles in international journals. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly … HAMBURG, Germany-- ( BUSINESS WIRE )--Akinn Group (Akinn) is pleased to announce today that Dr Andreas Dombret has been appointed its Independent … Goekbuget N, Dombret H, Bonifacio M, et al. Wife of Jean Gaspar MAXHER.0148328.. Patients older than age 55 years were included in th … Background: Patients with acute myeloid leukaemia (AML) positive for internal tandem duplication (ITD) mutations of FLT3 have poor outcomes. Between 2010 and 2018, Andreas Dombret served as a member of the Executive Board of the Deutsche Bundesbank, the German central bank; from 2014 to 2018 he was a member of the Supervisory Board of the European Central Bank; and from 2012 to 2018, he was a Board Director at the Bank for International Settlements. Dombret) is responsible for manuscript content and gave approval to submit the manuscript. Apart from serving on the board of the European School of Management & Technology (ESMT) in Berlin, Andreas Dombret is co-editor of the journals of „Central Banking", „Zeitschrift für das gesamte Kreditwesen" and Background: Differentiation based therapy by all trans retinoic acid (ATRA) and arsenic trioxide (ATO) results in cure of >90% of patients with acute promyelocytic leukemia (APL). doi: 10. Antithrombin (AT) replacement has been suggested to prevent venous thromboembolism (VTE) and thus may increase exposure to ASP. An international panel to provide updated evidence- and expert opinion-based recommendations for diagnosis and management of acute myeloid leukemia in adults includes a revised version of the ELN genetic categories, a proposal for a response category based on MRD status, and criteria for progressive disease. Abstract. 2 Leukemia Translational Laboratory Ex-Bundesbanker Dombret zur Bankenkrise: „Bei der Regulierung gibt es Nachholbedarf“. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. Conflict-of-interest disclosure: H. The median disease-free survival … Gemtuzumab ozogamicin (GO) is an antibody-drug conjugate consisting of a monoclonal antibody targeting CD33 linked to a cytotoxic derivative of calicheamicin. Buss, Christoph Faul, Monika Bruggemann, Arnold Ganser, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. After 20 years Induction therapy with cytarabine and an anthracycline remains a standard of care in AML. This case was filed in Santa Rosa County Courts, Santa Rosa County Courthouse located in Santa Rosa, Florida. The Institute was founded as a result of the motivation of Professor Gustave Roussy, the father of the concepts of "cross-boundary working" and "multi-disciplinary patient management". 1645. PLoS One 11 (2):e0148328, 10. 1. Dylan Dombret is 50 years old and was born on 05/26/1973. H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, Dr. Nach den Turbulenzen im Bankensektor müssen die Aufseher nach Ansicht des Ex-Bundesbankers die In 2010, an international expert panel, on behalf of the European LeukemiaNet (ELN), published recommendations for diagnosis and management of acute myeloid leukemia (AML). Ossenkoppele, Ignazia La Prognosis of Philadelphia-positive (Ph(+)) acute lymphoblastic leukemia (ALL) in the elderly has improved during the imatinib era. Quizartinib, an oral, highly potent, selective, type 2 FLT3 inhibitor, plus chemotherapy showed antitumour activity with an acceptable safety profile in patients with FLT3-ITD-positive newly … Dr. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the 4 The limits of regulation. The bigger issue is how to tackle the too-big-to-fail problem. Saya sinden cuma nyanyi Silahkan abang bergoyang Walau harus pulang pagi Asal saja akang senang.8 mg/m 2. Major advances have been made in the last decade toward a better understanding of the disease pathogenesis and the development of D Hoelzer 1 , R Bassan 2 , H Dombret 3 , A Fielding 4 , J M Ribera 5 , C Buske 6 ; ESMO Guidelines Committee. The standard combination is the 7+3, with a 7-day continuous infusion of cytarabine at the dosage of 100 or 200 mg/m 2 per day on days 1 to 7 and daunorubicin at 60 mg/m 2 per day on days 1 to 3. We analyzed ca … Background: Drug treatments for patients with high-risk myelodysplastic syndromes provide no survival advantage. Dombret) is responsible for manuscript content and gave approval to submit the manuscript. The addition of quizartinib to standard chemotherapy with or without allo-HCT, followed by continuation monotherapy for up to 3 years, resulted in improved overall survival in adults aged 18-75 years with FLT3-ITD-positive newly diagnosed AML.200209-1030OC. How unique is the name Dombret? Out of 6,311,504 records in the U.3202-2202 ni yltnacifingis gniworg neeb sah htrow ten siH . The EU is more exposed to the war, but they had some inflation before March 2022 Hervé Dombret 1 , John F Seymour 2 , Aleksandra Butrym 3 , Agnieszka Wierzbowska 4 , Dominik Selleslag 5 , Jun Ho Jang 6 , Rajat Kumar 7 , James Cavenagh 8 , Andre C Schuh 9 , Anna Candoni 10 , Christian Récher 11 , Irwindeep Sandhu 12 , Teresa Bernal del Castillo 13 , Haifa Kathrin Al-Ali 14 , Giovanni Martinelli 15 , Jose Falantes 16 Hervé Dombret's 865 research works with 51,640 citations and 9,652 reads, including: Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long Hi Dangdut Mania Karaokean yuk Jangan Lupa Like & Subcribenya Ya. We investigated dasatinib, another potent tyrosine kinase inhibitor, in combination with low-intensity chemotherapy. Literature searches, categorization of evidence, and arrival at consensus were done as previously.terbmoD eman eht tuoba stcaF nuF . Nicola Gökbuget 1 , Hervé Dombret 2 , Massimiliano Bonifacio 3 , Albrecht Reichle 4 , Carlos Graux 5 , Christoph Faul 6 , Helmut Diedrich 7 , Max S Topp 8 , Monika Brüggemann 9 , Heinz-August Horst 9 , Violaine Havelange 10 , Julia Stieglmaier 11 , Hendrik Wessels 11 , Vincent Haddad 12 , Jonathan E Benjamin 13 , Gerhard Zugmaier 11 , Dirk Case Summary. ning.